-61 % change
Extra-EU imports of CN 90222100 were down 61% in 2025 compared with 2020 (€25.5 million), calculated from Eurostat values.
Eurostat106.5 EUR million
EU exports of CN 90222100 to countries outside the EU were worth €106.5 million in 2025.
Eurostat67.7 EUR million
Trade between EU member states in CN 90222100 (intra-EU arrivals) came to €67.7 million in 2025.
EurostatSource: Eurostat
Why this market is moving now
- Extra-EU import value moved -61% from 2020 to 2025, a direct read on EU demand for sourced supply.
- Supply is concentrated: one country provided a large share of extra-EU imports in 2025.
- US employment in the core industry shifted -9% since 2020.
- Clinical research is active, with studies recruiting now.
What this market covers
Cancer treatment that places a sealed radioactive source inside or next to a tumor. It is used for prostate, cervical, breast and skin cancers.
Typical segments
- High dose rate brachytherapy
- Low dose rate seed implants
- Eye plaque therapy
- Electronic brachytherapy
Who buys
- Cancer centers
- Hospitals
- Radiation oncologists
Largest non-EU suppliers to the EU
| Country | Import value |
|---|---|
| United States from 1995 -> 2000) | 5.5 EUR million |
| Australia | 0.9 EUR million |
| Canada | 0.9 EUR million |
| China | 0.7 EUR million |
| Japan | 0.6 EUR million |
| United Kingdom | 0.4 EUR million |
Key figures
Each figure links to the page it came from.
| Figure | Value | Year | Source |
|---|---|---|---|
| The EU imported €10.0 million of products under CN code 90222100 (Apparatus based on the use of alpha, beta or gamma radiations, for medical, surgical,) from outside the EU in 2025. | 10.0 EUR million | 2025 | Eurostat |
| Extra-EU imports of CN 90222100 were down 61% in 2025 compared with 2020 (€25.5 million), calculated from Eurostat values. | -61 % change | 2025 | Eurostat |
| EU exports of CN 90222100 to countries outside the EU were worth €106.5 million in 2025. | 106.5 EUR million | 2025 | Eurostat |
| Trade between EU member states in CN 90222100 (intra-EU arrivals) came to €67.7 million in 2025. | 67.7 EUR million | 2025 | Eurostat |
| United States from 1995 -> 2000) was the largest non-EU supplier of CN 90222100 to the EU in 2025, with €5.5 million, or 55% of extra-EU imports. | 5.5 EUR million | 2025 | Eurostat |
| EU exports of CN 90222100 to the United States were €36.2 million in 2025. | 36.2 EUR million | 2025 | Eurostat |
| The average value of extra-EU imports of CN 90222100 was €87.23 per kilogram in 2025, calculated from Eurostat value and weight. | 87.23 EUR per kg | 2025 | Eurostat |
| Sweden was the largest EU exporter of CN 90222100 to non-EU countries in 2025, at €47.6 million. | 47.6 EUR million | 2025 | Eurostat |
| The EU had 1,791 enterprises in NACE class C2660 (Manufacture of irradiation, electromedical and electrotherapeutic equipment) in 2023. | 1,791 enterprises | 2023 | Eurostat |
| EU enterprises in NACE class C2660 had net turnover of €30.54 billion in 2023. | 30.54 EUR billion | 2023 | Eurostat |
| NACE class C2660 employed 74,126 people across the EU in 2021. | 74,126 persons employed | 2021 | Eurostat |
| The US had 298 private establishments in NAICS 334517 (Irradiation apparatus manufacturing) in 2025. | 298 establishments | 2025 | U.S. Bureau of Labor Statistics |
| NAICS 334517 employed an average of 12,771 people in US private industry in 2025. | 12,771 jobs | 2025 | U.S. Bureau of Labor Statistics |
| US employment in NAICS 334517 changed by -9% between 2020 (13,969 jobs) and 2025, calculated from BLS figures. | -9 % change | 2025 | U.S. Bureau of Labor Statistics |
| Average annual pay in US NAICS 334517 was $135,443 in 2025. | 135,443 USD per year | 2025 | U.S. Bureau of Labor Statistics |
| The FDA has recorded 48 510(k) clearances for devices named "brachytherapy". | 48 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| 2 of those clearances were issued from 2021 to 2025. | 2 510(k) clearances | 2025 | U.S. Food and Drug Administration (openFDA) |
| Best Medical International, Inc. holds 2 510(k) clearances for devices named "brachytherapy". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| Braxx Biotech Co., Ltd. holds 2 510(k) clearances for devices named "brachytherapy". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| C.R. Bard, Inc. holds 2 510(k) clearances for devices named "brachytherapy". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| Icad, Inc. holds 2 510(k) clearances for devices named "brachytherapy". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| Implant Sciences Corp. holds 2 510(k) clearances for devices named "brachytherapy". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| Isoaid, Llc holds 2 510(k) clearances for devices named "brachytherapy". | 2 510(k) clearances | 2026 | U.S. Food and Drug Administration (openFDA) |
| ClinicalTrials.gov lists 7,643 registered studies for the condition "prostate cancer". | 7,643 registered studies | 2026 | U.S. National Library of Medicine (ClinicalTrials.gov) |
| 1,221 of those studies were recruiting participants when checked in November 2026. | 1,221 recruiting studies | 2026 | U.S. National Library of Medicine (ClinicalTrials.gov) |
Companies to watch
Best Medical International, Inc.
2 FDA 510(k) clearances for devices named "brachytherapy".
Braxx Biotech Co., Ltd.
2 FDA 510(k) clearances for devices named "brachytherapy".
C.R. Bard, Inc.
2 FDA 510(k) clearances for devices named "brachytherapy".
Icad, Inc.
2 FDA 510(k) clearances for devices named "brachytherapy".
Implant Sciences Corp.
2 FDA 510(k) clearances for devices named "brachytherapy".
Isoaid, Llc
2 FDA 510(k) clearances for devices named "brachytherapy".
What the full report covers
- 1
Executive summary
The answer on two pages: size, growth and what drives it.
- 2
Market size and outlook
History, the current year and a five-year view with base, low and high cases.
- 3
Segments and regions
Splits by product, buyer and geography across the US, Europe and MEA.
- 4
Company profiles
The main players, how they compete and where they are investing.
- 5
Data and method
Every figure in Excel, with the sources and assumptions behind it.
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the European Union market - 03Market size, 2021 to 2025
Historical series and growth rates - 04Outlook to 2031
Base, low and high scenarios with stated assumptions - 05Rules, policy and deadlines
Regulation and programmes that change demand - 06Drivers and barriers
What accelerates or slows adoption, by customer segment - 07Prices, costs and margins
Unit economics where public data allows - 08Competitive landscape
8 to 12 company profiles with recent moves - 09Opportunities and risks
For new entrants, suppliers and investors - 10Method and sources
Every assumption and source, listed
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
How big is the EU brachytherapy market?
There is no single official market total. Eurostat trade data shows the EU imported €10.0 million of goods under CN 90222100 from outside the EU in 2025 and exported €106.5 million.
Where does the EU import brachytherapy from?
United States from 1995 -> 2000) was the largest non-EU supplier in 2025. The next largest were Australia, Canada, China.
What is the average import price of brachytherapy in the EU?
Dividing Eurostat import value by weight gives about €87.23 per kilogram for CN 90222100 in 2025.
Which EU countries export the most brachytherapy?
Sweden led EU exports to non-EU countries in 2025, followed by Netherlands, Germany.
How many brachytherapy devices are cleared by the FDA?
openFDA lists 48 510(k) clearances for devices named brachytherapy.
Which companies hold the most FDA clearances for brachytherapy?
By 510(k) count: Best Medical International, Inc., Braxx Biotech Co., Ltd., C.R. Bard, Inc., Icad, Inc..
Sources and method
The figures on this page come from the public sources listed below. Read how we work.
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, partner EXT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 10013598
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, flow import, 2020 VALUE_IN_EUROS 25546975; 2025 VALUE_IN_EUROS 10013598
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 106472002
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, partner INT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 67706312
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, partner US, flow import, 2025, VALUE_IN_EUROS 5500738
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, partner US, flow export, 2025, VALUE_IN_EUROS 36156847
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter EU27_2020, product 90222100, flow import, 2025, VALUE_IN_EUROS 10013598, QUANTITY_IN_100KG 1148
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
DS-045409, reporter SE, product 90222100, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 47594463
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
sbs_ovw_act, geo EU27_2020, nace_r2 C2660, indic_sbs ENT_NR, 2023, 1791
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
sbs_ovw_act, geo EU27_2020, nace_r2 C2660, indic_sbs NETTUR_MEUR, 2023, 30540
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
sbs_ovw_act, geo EU27_2020, nace_r2 C2660, indic_sbs EMP_NR, 2021, 74126
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 334517, 2025 (2026-11-04)
QCEW 2025 annual, US000, private, NAICS 334517, annual_avg_estabs 298
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 334517, 2025 (2026-11-04)
QCEW 2025 annual, US000, private, NAICS 334517, annual_avg_emplvl 12771
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 334517, 2025 (2026-11-04)
QCEW 2020 annual_avg_emplvl 13969; 2025 annual_avg_emplvl 12771
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 334517, 2025 (2026-11-04)
QCEW 2025 annual, US000, private, NAICS 334517, avg_annual_pay 135443
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances, device_name "brachytherapy" (2026-11-04)
openFDA device/510k device_name:"brachytherapy", sum of counts by decision_date = 48
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances, device_name "brachytherapy" (2026-11-04)
openFDA device/510k decision_date 2021-2025 count = 2
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances by applicant, device_name "brachytherapy" (2026-11-04)
applicant.exact "Best Medical International, Inc." count 2
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances by applicant, device_name "brachytherapy" (2026-11-04)
applicant.exact "Braxx Biotech Co., Ltd." count 2
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances by applicant, device_name "brachytherapy" (2026-11-04)
applicant.exact "C.R. Bard, Inc." count 2
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances by applicant, device_name "brachytherapy" (2026-11-04)
applicant.exact "Icad, Inc." count 2
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances by applicant, device_name "brachytherapy" (2026-11-04)
applicant.exact "Implant Sciences Corp." count 2
- U.S. Food and Drug Administration (openFDA): openFDA 510(k) clearances by applicant, device_name "brachytherapy" (2026-11-04)
applicant.exact "Isoaid, LLC" count 2
- U.S. National Library of Medicine (ClinicalTrials.gov): ClinicalTrials.gov API v2, condition "prostate cancer" (2026-11-04)
query.cond=prostate cancer totalCount 7643
- U.S. National Library of Medicine (ClinicalTrials.gov): ClinicalTrials.gov API v2, condition "prostate cancer", status recruiting (2026-11-04)
filter.overallStatus=RECRUITING totalCount 1221
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.
- Full table of contents
- Two sample chapters
- Method note and data outline